As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Thermo Fisher Scientific: Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, Cubist Systematic Strategies LLC, Twin Tree Management LP, HAP Trading LLC, BNP Paribas Financial Markets, Brant Point Investment Management LLC, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Credit Agricole S A, Hsbc Holdings PLC, Maven Securities LTD, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, Citigroup Inc., XY Capital Ltd, Jefferies Financial Group Inc., Baader Bank Aktiengesellschaft, Readystate Asset Management LP, Allianz Asset Management GmbH, Caas Capital Management LP, and Fulcrum Asset Management LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.